Indian anticoagulants market is estimated to grow at a CAGR of 8.8% during the forecast period. Growing CVD incidences have been leading to increasing demand for anticoagulants in the country. As per the American Heart Association (AHA), in India, the estimated prevalence of CVDs was estimated to be 54.5 million in 2016. One in 4 deaths in the country is reported due to CVDs with stroke and ischemic heart disease that are responsible for more than 80% of this burden. This is resulting in an increasing demand for anticoagulant treatment for acute coronary syndromes. It is effective to treat and prevent pulmonary emboli and venous thrombosis. Vitamin K antagonists are one of the oral anticoagulants demonstrated for long-term therapy of patients suffering from CHD, primarily after an acute coronary syndrome (ACS).
Get Free Sample link @ https://www.omrglobal.com/request-sample/indian-anticoagulants-market
The market is segmented based on type and application. Based on type, the market is classified into novel oral anticoagulants (NOACs), vitamin k antagonist, and heparin, and low molecular weight heparin (LMWH). To minimize the risk of stroke in appropriate atrial fibrillation (AF) patients, NOACs are now the ideal suggested drug class compared to warfarin, except for patients suffering from moderate to severe mitral stenosis or an artificial heart valve. NOACs comprises edoxaban, dabigatran, apixaban, and rivaroxaban. Based on application, the market is classified into a pulmonary embolism, atrial fibrillation/myocardial infarction (heart attack), deep vein thrombosis, and others.
A full report of Indian Anticoagulants Market available @ https://www.omrglobal.com/industry-reports/indian-anticoagulants-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Indian Anticoagulants Market by Type
- Novel Oral Anticoagulants (NOACs)
- Vitamin K Antagonist
- Heparin and Low Molecular Weight Heparin (LMWH)
Indian Anticoagulants Market by Application
- Pulmonary Embolism
- Atrial Fibrillation/Myocardial Infarction (Heart Attack)
- Deep Vein Thrombosis (DVT)
- Others
Company Profiles
- Bristol Myers Squibb Co.
- Overview
- Product Portfolio
- Recent Activities
- Cipla, Ltd.
- Daiichi Sankyo Company, Ltd.
- Reddy’s Laboratories
- Gland Pharma, Ltd.
- Glenmark Pharmaceuticals, Ltd.
- Lupin, Ltd.
- Morepen Laboratories, Ltd.
- Pfizer, Inc.
- Sun Pharmaceutical Industries, Ltd.
The Report Covers
- Comprehensive research methodology of the Indian anticoagulants market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Indian anticoagulants market.
- Insights about market determinants that are stimulating the Indian anticoagulants market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-anticoagulants-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
